Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial.

Iain C MacdougallSunil BhandariClaire WhiteStefan D AnkerKenneth FarringtonPhilip A KalraPatrick B Mark John Joseph Valentine McMurrayChante ReidMichele RobertsonCharles R V TomsonDavid C WheelerChristopher G WinearlsIan Fordnull null

Published in: Journal of the American Society of Nephrology : JASN (2020)

The high-dose and low-dose IV iron groups exhibited identical infection rates. Risk of a first cardiovascular event strongly associated with a recent infection.

Keyphrases

high dose
low dose
end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
stem cell transplantation
clinical trial
prognostic factors
study protocol
patient reported